demonstrate VALUE
assess IMPACT
realize OUTCOMES
SERVICES
Turning evidence into access...and access into real-world impact...
Selected disseminations across U.S. and ex-U.S. congresses and scientific forums
Management
Sameer Kotak is the Founder of Yorker Health, with over 25 years of experience leading value, access, and evidence strategy across the pharmaceutical and life sciences industry.
He previously held senior roles at Pfizer, supporting Global Value & Evidence as well as Business Development and Corporate Strategy, and earlier worked at Allergan and boutique consulting firms. Sameer holds degrees from the University of Mumbai, Long Island University, and Columbia Business School, along with executive certifications from Harvard and Wharton.
Ava Academy
Ava Academy is our CSR initiative. We are humbled to support the educational and extra curricular needs of underprivileged children in rural India.
Sameer's daughter (Ava) is actively engaged in this initiative and we plan to expand our social causes to other parts of the world.
We sponsor a pre-school/day-care center in Nashik (Maharashtra, India) which provides free onsite daycare and child development activities for kids whose parents work as farm laborers and are unable to afford appropriate care for their children.
We also proudly facilitate women's empowerment initiatives such as basics of fiscal literacy, nutrition and legal/moral rights.
We match 100% donations [up to $20,000] made towards our CSR initiative.
GET IN TOUCH
Let's innovate together!
+1.201.707.3209
Single Parent Owned Enterprise
ABOUT
Yorker Health provides advisory services across Value & Evidence Platforms, Market Access, Real-World Data Strategy, Commercial Strategy, and Management Consulting to biopharmaceutical, medical device, and life-sciences companies.
We partner with asset- and portfolio-level leaders across Commercial, HEOR, Medical Affairs, and Market Access to support decision-making throughout the development and lifecycle-management continuum—from early clinical strategy through launch, access optimization, and post-LOE planning.
We also work closely with venture-backed and privately held clinical-stage and late-stage organizations to design, build, and operationalize Value, Access, and Real-World Evidence functions, aligning evidence generation, payer strategy, and commercial execution to maximize patient access and enterprise value.